Perceptive Advisors - ADMA BIOLOGICS INC ownership

ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 98 filers reported holding ADMA BIOLOGICS INC in Q2 2020. The put-call ratio across all filers is 1.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of ADMA BIOLOGICS INC
ValueSharesWeighting
Q3 2023$25,003,862
-43.1%
6,984,319
-41.3%
0.83%
-34.4%
Q2 2023$43,911,941
+11.5%
11,900,2550.0%1.27%
+9.3%
Q1 2023$39,389,844
-14.7%
11,900,2550.0%1.16%
-10.3%
Q4 2022$46,172,989
+73.8%
11,900,255
+8.8%
1.30%
+68.2%
Q3 2022$26,568,000
+16.5%
10,933,387
-5.1%
0.77%
+8.0%
Q2 2022$22,812,000
+4.5%
11,521,102
-3.5%
0.71%
+63.4%
Q1 2022$21,838,000
-35.1%
11,933,387
-50.0%
0.44%
+68.1%
Q4 2021$33,652,000
+124.6%
23,866,774
+80.0%
0.26%
+19.3%
Q3 2021$14,986,000
-71.8%
13,262,375
-60.0%
0.22%
-36.8%
Q2 2021$53,072,000
+81.8%
33,169,604
+100.0%
0.34%
-6.5%
Q1 2021$29,189,000
-9.7%
16,584,8020.0%0.37%
+6.3%
Q4 2020$32,340,000
-18.4%
16,584,8020.0%0.35%
-40.1%
Q3 2020$39,638,000
-18.4%
16,584,8020.0%0.58%
-26.4%
Q2 2020$48,593,000
+1.7%
16,584,8020.0%0.79%
-36.7%
Q1 2020$47,764,000
+3.6%
16,584,802
+44.0%
1.24%
+36.0%
Q4 2019$46,084,000
-10.1%
11,521,1020.0%0.92%
-33.7%
Q3 2019$51,268,000
+15.0%
11,521,1020.0%1.38%
+35.0%
Q2 2019$44,586,000
+80.4%
11,521,102
+76.7%
1.02%
+46.8%
Q1 2019$24,715,000
+70.0%
6,521,1020.0%0.70%
+26.0%
Q4 2018$14,542,000
-64.1%
6,521,1020.0%0.55%
-48.9%
Q3 2018$40,496,000
+37.7%
6,521,1020.0%1.08%
+40.5%
Q2 2018$29,410,000
+67.3%
6,521,102
+70.7%
0.77%
+56.7%
Q1 2018$17,577,000
+43.3%
3,821,1020.0%0.49%
+20.9%
Q4 2017$12,266,000
+176.1%
3,821,102
+164.9%
0.41%
+378.8%
Q3 2017$4,442,000
+60.4%
1,442,204
+100.0%
0.08%
-38.8%
Q2 2017$2,769,000
-21.3%
721,1020.0%0.14%
-30.5%
Q1 2017$3,519,000
-4.7%
721,1020.0%0.20%
-24.0%
Q4 2016$3,692,000
-30.7%
721,102
-1.9%
0.26%
-23.5%
Q3 2016$5,327,000734,7930.34%
Other shareholders
ADMA BIOLOGICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 9,104,275$32,593,30510.83%
Altium Capital Management LP 2,723,011$9,748,3795.08%
Velan Capital Investment Management LP 1,736,100$6,215,2385.01%
AWM Investment Company, Inc. 5,999,872$21,479,5423.17%
Mesirow Financial Investment Management, Inc. 72,677$260,1841.13%
Caligan Partners LP 597,513$2,139,0970.98%
Perceptive Advisors 6,984,319$25,003,8620.83%
OBERWEIS ASSET MANAGEMENT INC/ 2,078,400$7,440,6720.79%
TANG CAPITAL MANAGEMENT LLC 1,360,000$4,868,8000.69%
EAM Investors, LLC 967,146$3,462,3830.67%
View complete list of ADMA BIOLOGICS INC shareholders